CXCR4 S338X clonality is an important determinant of ibrutinib outcomes in patients with Waldenström macroglobulinemia.
Joshua N GustineLian XuNicholas TsakmaklisMaria G DemosAmanda KofidesJiaji G ChenXia LiuManit MunshiMaria Luisa GuerreraGloria G ChanChristopher J PattersonAndrew KeezerKirsten MeidToni DubeauGuang YangZachary R HunterSteven P TreonJorge J CastilloPublished in: Blood advances (2020)